S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
S&P 500   2,470.50 (-4.41%)
DOW   20,943.51 (-4.44%)
QQQ   182.31 (-4.25%)
AAPL   240.91 (-5.26%)
FB   159.60 (-4.32%)
MSFT   152.11 (-3.55%)
GOOGL   1,102.10 (-5.15%)
AMZN   1,907.70 (-2.16%)
CGC   13.58 (-5.83%)
NVDA   243.07 (-7.79%)
BABA   187.56 (-3.56%)
MU   39.89 (-5.16%)
GE   7.04 (-11.34%)
TSLA   481.56 (-8.10%)
AMD   43.66 (-4.00%)
T   28.05 (-3.77%)
ACB   0.81 (-11.00%)
F   4.40 (-8.90%)
NFLX   364.08 (-3.04%)
BAC   19.77 (-6.88%)
GILD   72.51 (-3.01%)
PRI   84.16 (-4.88%)
DIS   94.92 (-1.74%)
Log in

Calithera Biosciences News Headlines (NASDAQ:CALA)

$4.11
-0.33 (-7.43 %)
(As of 04/1/2020 04:00 PM ET)
Today's Range
$3.99
Now: $4.11
$4.38
50-Day Range
$3.21
MA: $5.78
$7.80
52-Week Range
$2.45
Now: $4.11
$8.04
Volume340,400 shs
Average Volume532,508 shs
Market Capitalization$265.85 million
P/E RatioN/A
Dividend YieldN/A
Beta2.15

Headlines

Calithera Biosciences (NASDAQ CALA) News Headlines

Source:
DateHeadline
Calithera Biosciences Inc (NASDAQ:CALA) Short Interest UpdateCalithera Biosciences Inc (NASDAQ:CALA) Short Interest Update
www.americanbankingnews.com - April 1 at 4:36 AM
 Analysts Expect Calithera Biosciences Inc (NASDAQ:CALA) to Announce -$0.36 EPS Analysts Expect Calithera Biosciences Inc (NASDAQ:CALA) to Announce -$0.36 EPS
www.americanbankingnews.com - March 28 at 5:46 PM
Have Insiders Been Buying Calithera Biosciences, Inc. (NASDAQ:CALA) Shares?Have Insiders Been Buying Calithera Biosciences, Inc. (NASDAQ:CALA) Shares?
finance.yahoo.com - March 28 at 3:47 PM
Calithera Biosciences (NASDAQ:CALA) Receives New Coverage from Analysts at Jefferies Financial GroupCalithera Biosciences (NASDAQ:CALA) Receives New Coverage from Analysts at Jefferies Financial Group
www.americanbankingnews.com - March 27 at 10:14 PM
Calithera Biosciences (NASDAQ:CALA) Price Target Cut to $7.00Calithera Biosciences (NASDAQ:CALA) Price Target Cut to $7.00
www.americanbankingnews.com - March 27 at 10:25 AM
Calithera Biosciences Inc (NASDAQ:CALA) to Post Q1 2021 Earnings of ($0.49) Per Share, William Blair ForecastsCalithera Biosciences Inc (NASDAQ:CALA) to Post Q1 2021 Earnings of ($0.49) Per Share, William Blair Forecasts
www.americanbankingnews.com - March 16 at 2:26 AM
Calithera Biosciences Inc to Post Q3 2020 Earnings of ($0.33) Per Share, SVB Leerink Forecasts (NASDAQ:CALA)Calithera Biosciences Inc to Post Q3 2020 Earnings of ($0.33) Per Share, SVB Leerink Forecasts (NASDAQ:CALA)
www.americanbankingnews.com - March 16 at 1:38 AM
Calithera Biosciences (CALA) "Outperform" Rating Reiterated at SVB LeerinkCalithera Biosciences' (CALA) "Outperform" Rating Reiterated at SVB Leerink
www.americanbankingnews.com - March 14 at 7:44 AM
Calithera Biosciences (NASDAQ:CALA) Posts  Earnings Results, Misses Expectations By $0.02 EPSCalithera Biosciences (NASDAQ:CALA) Posts Earnings Results, Misses Expectations By $0.02 EPS
www.americanbankingnews.com - March 12 at 9:41 AM
Edited Transcript of CALA earnings conference call or presentation 11-Mar-20 9:00pm GMTEdited Transcript of CALA earnings conference call or presentation 11-Mar-20 9:00pm GMT
finance.yahoo.com - March 12 at 9:18 AM
Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q4 2019 Results - Earnings Call TranscriptCalithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 11 at 10:54 PM
Calithera Biosciences Inc (CALA) Q4 2019 Earnings Call TranscriptCalithera Biosciences Inc (CALA) Q4 2019 Earnings Call Transcript
www.fool.com - March 11 at 9:30 PM
Calithera Biosciences EPS misses by $0.02Calithera Biosciences EPS misses by $0.02
seekingalpha.com - March 11 at 5:54 PM
Calithera Biosciences, Inc. to Host Earnings CallCalithera Biosciences, Inc. to Host Earnings Call
finance.yahoo.com - March 11 at 5:54 PM
Calithera Biosciences Reports Fourth Quarter 2019 Financial Results and Recent HighlightsCalithera Biosciences Reports Fourth Quarter 2019 Financial Results and Recent Highlights
finance.yahoo.com - March 11 at 5:54 PM
Calithera Biosciences Inc (NASDAQ:CALA) Receives Average Rating of "Buy" from BrokeragesCalithera Biosciences Inc (NASDAQ:CALA) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - March 9 at 2:50 AM
Calithera Biosciences Provides Corporate Updates and Announces Key Executive Promotions to Drive Continued Growth of the CompanCalithera Biosciences Provides Corporate Updates and Announces Key Executive Promotions to Drive Continued Growth of the Compan
www.bloomberg.com - March 5 at 3:57 PM
Calithera to Participate in the 9th Annual SVB Leerink Global Healthcare ConferenceCalithera to Participate in the 9th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 19 at 9:13 AM
Is Calithera Biosciences, Inc.'s (NASDAQ:CALA) CEO Paid Enough Relative To Peers?Is Calithera Biosciences, Inc.'s (NASDAQ:CALA) CEO Paid Enough Relative To Peers?
finance.yahoo.com - January 30 at 1:03 PM
Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial GuidanceCalithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance
finance.yahoo.com - January 13 at 4:46 PM
Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - January 3 at 4:59 PM
Hedge Funds Are Dumping Calithera Biosciences Inc (CALA)Hedge Funds Are Dumping Calithera Biosciences Inc (CALA)
finance.yahoo.com - December 13 at 7:07 PM
Data from Investigator-Sponsored Phase 2 Study of Calithera’s Telaglenastat with Azacitidine in Myelodysplastic Syndrome to be Presented at ASH Annual Meeting 2019Data from Investigator-Sponsored Phase 2 Study of Calithera’s Telaglenastat with Azacitidine in Myelodysplastic Syndrome to be Presented at ASH Annual Meeting 2019
finance.yahoo.com - December 6 at 9:23 AM
Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - December 5 at 8:01 AM
Imagine Owning Calithera Biosciences (NASDAQ:CALA) While The Price Tanked 64%Imagine Owning Calithera Biosciences (NASDAQ:CALA) While The Price Tanked 64%
finance.yahoo.com - December 2 at 2:45 PM
Edited Transcript of CALA earnings conference call or presentation 12-Nov-19 10:00pm GMTEdited Transcript of CALA earnings conference call or presentation 12-Nov-19 10:00pm GMT
finance.yahoo.com - November 23 at 12:33 PM
Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q3 2019 Results - Earnings Call TranscriptCalithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 11:07 PM
Calithera Biosciences Inc (CALA) Q3 2019 Earnings Call TranscriptCalithera Biosciences Inc (CALA) Q3 2019 Earnings Call Transcript
www.nasdaq.com - November 12 at 11:07 PM
Calithera Biosciences Reports Third Quarter 2019 Financial Results and Recent HighlightsCalithera Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights
finance.yahoo.com - November 12 at 6:06 PM
Calithera to Present Preclinical Data from IL4I1 and CD73 Programs at the Society for Immunotherapy of Cancer (SITC) Annual MeetingCalithera to Present Preclinical Data from IL4I1 and CD73 Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - November 5 at 12:43 PM
Calithera Biosciences to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019Calithera Biosciences to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019
finance.yahoo.com - November 4 at 9:29 AM
Read This Before Selling Calithera Biosciences, Inc. (NASDAQ:CALA) SharesRead This Before Selling Calithera Biosciences, Inc. (NASDAQ:CALA) Shares
finance.yahoo.com - October 19 at 1:35 PM
Calithera (CALA) Completes Enrollment in Mid-Stage RCC StudyCalithera (CALA) Completes Enrollment in Mid-Stage RCC Study
finance.yahoo.com - October 7 at 5:32 PM
Calithera Biosciences moves forward with Cantata trialCalithera Biosciences moves forward with Cantata trial
seekingalpha.com - October 3 at 9:32 AM
Calithera Biosciences Completes Patient Enrollment in Randomized CANTATA Trial of Telaglenastat and Cabozantinib in Advanced Renal Cell CarcinomaCalithera Biosciences Completes Patient Enrollment in Randomized CANTATA Trial of Telaglenastat and Cabozantinib in Advanced Renal Cell Carcinoma
finance.yahoo.com - October 3 at 9:32 AM
Calithera Announces Acceptance of Two Abstracts for Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual MeetingCalithera Announces Acceptance of Two Abstracts for Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
finance.yahoo.com - October 1 at 4:51 PM
New Data Presented at ESMO Congress 2019 from the Arginase Inhibitor INCB001158 Alone and in Combination with PembrolizumabNew Data Presented at ESMO Congress 2019 from the Arginase Inhibitor INCB001158 Alone and in Combination with Pembrolizumab
finance.yahoo.com - September 29 at 4:40 PM
Data From Randomized Phase 2 ENTRATA Study Demonstrate Telaglenastat with Everolimus Improves Progression-Free Survival in Renal Cell CarcinomaData From Randomized Phase 2 ENTRATA Study Demonstrate Telaglenastat with Everolimus Improves Progression-Free Survival in Renal Cell Carcinoma
finance.yahoo.com - September 28 at 3:45 AM
Calithera Biosciences Enters Oversold TerritoryCalithera Biosciences Enters Oversold Territory
finance.yahoo.com - September 27 at 5:32 PM
Calithera to Host Webcast Conference Call for Analysts and Investors During European Society for Medical Oncology (ESMO) Congress 2019Calithera to Host Webcast Conference Call for Analysts and Investors During European Society for Medical Oncology (ESMO) Congress 2019
finance.yahoo.com - September 26 at 8:54 PM
Implied Volatility Surging for Calithera (CALA) Stock OptionsImplied Volatility Surging for Calithera (CALA) Stock Options
finance.yahoo.com - September 26 at 3:53 PM
Calithera to Present at the 2019 Cantor Global Healthcare ConferenceCalithera to Present at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 25 at 4:48 PM
Calithera Biosciences, Inc. (NASDAQ:CALA): Is It Growing Too Fast?Calithera Biosciences, Inc. (NASDAQ:CALA): Is It Growing Too Fast?
finance.yahoo.com - September 19 at 1:08 PM
Calithera to Participate in Wells Fargo Healthcare Conference and Citi 14th Annual Biotech ConferenceCalithera to Participate in Wells Fargo Healthcare Conference and Citi 14th Annual Biotech Conference
finance.yahoo.com - August 28 at 12:29 PM
Is Calithera Biosciences, Inc.'s (NASDAQ:CALA) CEO Pay Justified?Is Calithera Biosciences, Inc.'s (NASDAQ:CALA) CEO Pay Justified?
finance.yahoo.com - August 23 at 12:04 PM
Edited Transcript of CALA earnings conference call or presentation 8-Aug-19 9:00pm GMTEdited Transcript of CALA earnings conference call or presentation 8-Aug-19 9:00pm GMT
finance.yahoo.com - August 10 at 11:26 AM
Calithera Biosciences EPS beats by $0.07Calithera Biosciences EPS beats by $0.07
seekingalpha.com - August 9 at 1:32 AM
Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q2 2019 Results - Earnings Call TranscriptCalithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 1:32 AM
Calithera Biosciences Reports Second Quarter 2019 Financial Results and Recent HighlightsCalithera Biosciences Reports Second Quarter 2019 Financial Results and Recent Highlights
finance.yahoo.com - August 9 at 1:32 AM
Our Take On Calithera BiosciencesOur Take On Calithera Biosciences
seekingalpha.com - August 6 at 11:11 PM
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Featured Article: Trading Ex-Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel